Pulmonology
Conference Coverage
Biologics linked to fewer hospitalizations after asthma exacerbation
The study adds to growing data that biologics offer better long-term outcomes and could reduce health care utilization.
From the Journals
Paxlovid tied to benefits in high-risk patients with COVID
No significant benefit was observed in patients who were not immunocompromised.
From the Journals
Supplemental oxygen fails to improve echocardiographic measures in PE patients
The proportions of patients with normalized RV/LV ratios were similar with and without supplemental oxygen.
Conference Coverage
Dietary changes to microbiome may improve lung function
What we eat and what’s in the gut may influence lung health for better or worse.
Conference Coverage
Short, long-lasting bronchodilators similar for exacerbated COPD
Long-lasting bronchodilators are recommended by the Gold Report, but clinical evidence was lacking in this population.
Conference Coverage
Respiratory infections, asthma rise before type 2 diabetes
Taken together, the data suggest that subacute inflammation manifesting in asthma as well as the onset of asthma or an acute infection may be a...
Article
Progressive Pulmonary Fibrosis: Understanding Its Many Forms
Article
Long-Awaited RSV Vaccines Now Available for Older Adults and Pediatric Patients
Article
Tuberculosis Management: Returning to Pre-Pandemic Priorities
From the Journals
Severity score predicts mortality in pulmonary tuberculosis
A novel three-pronged assessment tool showed promise to inform treatment and improve outcomes.
From the Journals
Pulmonary aspergillosis predicts poor outcomes in critically ill flu patients
Influenza-associated pulmonary aspergillosis was associated with increased mortality, more complications, longer ICU stays, and more organ...